Literature DB >> 36407

Purification and characterization of a human neutrophil neutral protease. The neutral peptide-generating protease.

J S Coblyn, K F Austen, B U Wintroub.   

Abstract

A human neutrophil neutral protease which generates a low molecular weight peptide from a plasma protein substrate and cleaves the basic amino acid ester substrates alpha-N-p-tosyl-l-arginine methyl ester HCl, alpha-N-benzoyl-l-arginine-methyl ester HCl, and alpha-N-carbobenzoxy-l-lysine-p-nitrophenyl ester has been purified to homogeneity and distinguished from the known lysosomal neutrophil proteases. The starting activity was obtained from purified human neutrophils by homogenization, sedimentation by low-speed centrifugation, and high salt elution of the insoluble material. Purification was achieved by aprotinin-affinity chromatography, precipitation at low ionic strength, and gel filtration. The overall recovery, relative to the activity in the starting eluate of the neutrophil fraction, was congruent with50% with a 200- to 400-fold increase in specific activity. After treatment with diisopropylfluorophosphate to eliminate autodegradation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis of reduced and unreduced protein gave a single protein band of 29,000-30,000 mol wt. The isoelectric point determined in sucrose gradients ranged from pH 7.8 to 8.3 with a peak at pH 8.0. This neutrophil protease, like cathepsin G and elastase, is composed of a single polypeptide chain of congruent with30,000 mol wt, but differs from cathepsin G and elastase in its less cationic isoelectric point and its failure to cleave synthetic substrates presenting an aromatic amino acid ester linkage and alanyl peptide bonds, respectively.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36407      PMCID: PMC372041          DOI: 10.1172/JCI109400

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  The determination of human plasminogen using Nalpha-CBZ-L-lysin p-nitrophenyl ester as substrate.

Authors:  R M Silverstein
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

2.  Investigation of serum trypsin and related substances. I. The quantitative demonstration of trypsinlike activity in human blood serum by a micromethod.

Authors:  A M SIEGELMAN; A S CARLSON; T ROBERTSON
Journal:  Arch Biochem Biophys       Date:  1962-04       Impact factor: 4.013

3.  A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin.

Authors:  B C HUMMEL
Journal:  Can J Biochem Physiol       Date:  1959-12

4.  Photometric method for estimation of elastase activity.

Authors:  L A SACHAR; K K WINTER; N SICHER; S FRANKEL
Journal:  Proc Soc Exp Biol Med       Date:  1955-11

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Cationic proteins from human neutrophil granulocytes. Evidence for their chymotrypsin-like properties.

Authors:  R Rindler-Ludwig; H Braunsteiner
Journal:  Biochim Biophys Acta       Date:  1975-02-27

7.  Identification and characterization of arylsulfatase A and B of the rat basophil leukemia tumor.

Authors:  S I Wasserman; K F Austen
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

8.  A rapid method for purification of human granulocyte cationic neutral proteases: purification and characterization of human granulocyte chymotrypsin-like enzyme.

Authors:  G Feinstein; A Janoff
Journal:  Biochim Biophys Acta       Date:  1975-10-22

9.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes.

Authors:  B Dewald; R Rindler-Ludwig; U Bretz; M Baggiolini
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more
  8 in total

1.  The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase.

Authors:  S L Silverman; E S Cathcart; M Skinner; A S Cohen
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

2.  Confirmation of direct angiotensin formation by kallikrein.

Authors:  H Maruta; K Arakawa
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

3.  Cytolytic effects of neutrophils: role for a membrane-bound neutral proteinase.

Authors:  S Pontremoli; E Melloni; M Michetti; O Sacco; B Sparatore; F Salamino; G Damiani; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  Identification of a human neutrophil angiotension II-generating protease as cathepsin G.

Authors:  M G Tonnesen; M S Klempner; K F Austen; B U Wintroub
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

5.  Cleavage of fibrinogen by the human neutrophil neutral peptide-generating protease.

Authors:  B U Wintroub; J S Coblyn; C E Kaempfer; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates.

Authors:  F Dallegri; G Frumento; A Ballestrero; R Goretti; A Torresin; F Patrone
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

7.  A human neutrophil-dependent pathway for generation of angiotensin II: purification and physicochemical characterization of the plasma protein substrate.

Authors:  B U Wintroub; L B Klickstein; C E Kaempfer; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

8.  A human neutrophil-dependent pathway for generation of angiotensin II. Purification of the product and identification as angiotensin II.

Authors:  B U Wintroub; L B Klickstein; K W Watt
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.